Reply

Zhewen Ren^{1

2

3}, Pomme I H G Simons^{1

2

3}, Anke Wesselius^{4

5}, Coen D A Stehouwer^{2

3

6}, Martijn C G J Brouwers^{1

3}

Affiliations

¹ Division of Endocrinology and Metabolic Diseases, Department of Internal MedicineMaastricht University Medical CenterMaastrichtThe Netherlands.
² Laboratory for Metabolism and Vascular MedicineMaastricht UniversityMaastrichtThe Netherlands.
³ CARIM School for Cardiovascular DiseasesMaastricht UniversityMaastrichtThe Netherlands.
⁴ NUTRIM School for Nutrition and Translational Research in MetabolismMaastricht UniversityMaastrichtThe Netherlands.
⁵ Department of EpidemiologyMaastricht UniversityMaastrichtThe Netherlands.
⁶ Division of General Internal Medicine, Department of Internal MedicineMaastricht University Medical CenterMaastrichtThe Netherlands.

Zhewen Ren et al. Hepatology. 2022 Dec.

. 2022 Dec;76(6):E129-E130.

doi: 10.1002/hep.32611. Epub 2022 Jun 24.

Zhewen Ren^{1

2

3}, Pomme I H G Simons^{1

2

3}, Anke Wesselius^{4

5}, Coen D A Stehouwer^{2

3

6}, Martijn C G J Brouwers^{1

3}

¹ Division of Endocrinology and Metabolic Diseases, Department of Internal MedicineMaastricht University Medical CenterMaastrichtThe Netherlands.
² Laboratory for Metabolism and Vascular MedicineMaastricht UniversityMaastrichtThe Netherlands.
³ CARIM School for Cardiovascular DiseasesMaastricht UniversityMaastrichtThe Netherlands.
⁴ NUTRIM School for Nutrition and Translational Research in MetabolismMaastricht UniversityMaastrichtThe Netherlands.
⁵ Department of EpidemiologyMaastricht UniversityMaastrichtThe Netherlands.
⁶ Division of General Internal Medicine, Department of Internal MedicineMaastricht University Medical CenterMaastrichtThe Netherlands.

No abstract available

References

1. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115:1343–51.
1. Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro‐Paavonen A, Westerbacka J, et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 2006;49:1–11.
1. Brouwers MCGJ, Simons N, Stehouwer CDA, Isaacs A. Non‐alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality. Diabetologia. 2020;63:253–60.
1. Ren Z, Simons PIHG, Wesselius A, Stehouwer CDA, Brouwers MCGJ. Relationship between NAFLD and coronary artery disease: a mendelian randomization study. Hepatology. 2022 Apr 20. https://doi.org/10.1002/hep.32534 . [Epub ahead of print] - DOI
1. Brouwers MCGJ, Simons N, Stehouwer CDA, Koek GH, Schaper NC, Isaacs A. Relationship between nonalcoholic fatty liver disease susceptibility genes and coronary artery disease. Hepatol Commun. 2019;3:587–96.